{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/0299-6220#drug","name":"NEMLUVIO","alternateName":"nemolizumab-ilto","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0299-6220"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA761390"},{"@type":"PropertyValue","propertyID":"UNII","value":"GN465U8B72"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"e9229ef1-ac60-4c24-afb6-009d3c781687"}],"activeIngredient":"NEMOLIZUMAB","administrationRoute":["SUBCUTANEOUS"],"dosageForm":"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Galderma Laboratories, L.P."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA761390","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9229ef1-ac60-4c24-afb6-009d3c781687","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0299-6220"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-03T16:26:33.086Z"}}